Professor Mark Stoové is Head of the Public Health Discipline and a co-Head of the HIV Elimination Program at Burnet Institute. He has researched the transmission and impact of sexually transmitted and blood borne viruses among key risk populations for almost 20 years. His research program undertakes sexually transmitted and blood borne virus surveillance nationally and within specific jurisdictions across Australia. He also specialises in behavioural epidemiology, data linkage, and implementation science projects focused on reducing the transmission and burden of infectious diseases. His projects include bio-behavioural cohort studies of gay, bisexual and other men who have sex with men and people who inject drugs.

Winnie is the Program Manager for Hepatitis Queensland, responsible for managing the strategic planning, implementation and evaluation of key programs to strengthen viral hepatitis services across Queensland. Her passion for promoting meaningful conversations, driving action, and bringing about positive change is evident in her work, which spans over fourteen years across the not-for-profit, primary care, and public domain. Winnie is deeply committed to harnessing the workforce and cultivating genuine partnerships to develop opportunities and innovative projects that will create positive social change for people living with or at risk of viral hepatitis.

Dr John Rule is the Senior Research Manager at the National Association of People living with HIV Australia (NAPWHA). John has a social science background and has published research in the areas of HIV care and support, community development and health systems strengthening. At NAPWHA, the national HIV advocacy organisation, John contributes to research data dissemination for PLHIV on a range of research studies and is engaged in the national development of programs for quality PLHIV care. He has worked in Australia and overseas as an advocate for HIV-positive people for over 25 years.

Dr. Alexandra King is a member of Nipissing First Nation (Ontario). She is the Cameco Chair in Indigenous Health and Wellness at the University of Saskatchewan (USask), co-lead of Pewaseskwan (the Indigenous Wellness Research Group) and an Internist with the Saskatchewan Health Authority. She supports Indigenous communities in improving health and wellness outcomes, bringing leadership in culturally safe and responsive research and care.

Dr Doherty is the Director of the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes (HHS) at the World Health Organization (WHO). Appointed on the 1 February 2020, Dr Doherty has more than 25 years of experience working in HIV and infectious diseases, including leading WHO’s normative and programmatic work focusing on expanding HIV treatment to all and reducing inequalities in access to the most effective anti-retroviral drugs for people living with HIV. Dr Doherty is a trained epidemiologist and infectious disease specialist and has published over 110 peer-reviewed articles and book chapters. She received her MD from Harvard Medical School and her MPH and PhD in Infectious Disease Epidemiology from JHU Bloomberg School of Public Health. Under her leadership as Director, HHS department, the department works to maintain and expand global efforts to end AIDS and the epidemics of hepatitis and sexually transmitted infections by 2030 with a strong emphasis on service integration and strengthening primary health care within the framework of UHC, while focusing on vulnerable populations and countries with the highest burden.

Peter Vickerman is a Professor in infectious disease modeling at the University of Bristol. With more than 25 years’ experience in infectious disease modeling. His research focuses on the use of mathematical modeling to help understand the transmission of different infectious diseases and the impact and cost-effectiveness of prevention measures.

Sarah Larney is an Associate Professor in the Faculty of Medicine at the University of Montreal and principal researcher at the Research Centre of the Central Hospital of the University of Montreal. Her work focuses on harm reduction for people who inject drugs